Undocumented patient information: an impediment to quality of care.

PURPOSE Poor documentation in medical records might reduce the quality of care and undermine analyses based on retrospective chart reviews. We assessed the documentation of cardiac risk factors and cardiac history in the records of patients hospitalized with myocardial infarction or heart failure. METHODS We performed a retrospective cohort study involving direct chart audit of all consecutive hospitalizations for myocardial infarction (n = 2,109) or heart failure (n = 3,392) in Nova Scotia, Canada, from October 15, 1997, to October 14, 1998. The main outcome measures were the documentation rates for prespecified clinical items, including cardiac risk factors and history of myocardial infarction or heart failure, which were recognized as indicators of the quality of care for the conditions under study. RESULTS Information was not documented in a high proportion of cases, ranging from 9% (smoking) to 58% (previous history of heart failure) in charts from patients hospitalized for myocardial infarction, and from 19% (smoking) to 69% (hyperlipidemia) in charts from heart failure hospitalizations. Lack of documentation was more common in women and the elderly. CONCLUSION Documentation of important clinical information is poor even in the hospital charts of patients with severe conditions. This quality-of-care issue has implications for health services and outcomes research, including the development of report cards.

[1]  D Draper,et al.  Changes in quality of care for five diseases measured by implicit review, 1981 to 1986. , 1990, JAMA.

[2]  C. O'connor,et al.  Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. , 1997, The American journal of cardiology.

[3]  G. Fonarow,et al.  Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction: Data From the National Registry of Myocardial Infarction 3 , 2001, Circulation.

[4]  J. Wright,et al.  Reducing the risk after coronary artery bypass surgery: documentation of risk factors and communication between hospital and general practice. , 1997, Public health.

[5]  J. Gore,et al.  Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants. , 1998, American heart journal.

[6]  A. Garber Using Cost-Effectiveness Analysis To Target Cholesterol Reduction , 2000, Annals of Internal Medicine.

[7]  J. Cox Optimizing disease management at a health care system level: the rationale and methods of the improving cardiovascular outcomes in Nova Scotia (ICONS) study. , 1999, The Canadian journal of cardiology.

[8]  H. Heekeren,et al.  Quality of documentation in medical reports of diabetic patients. , 1996, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[9]  J. Cox The challenge with tracking health outcomes. , 2001, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[10]  E. McGlynn,et al.  Part 2: Measuring Quality of Care , 1996 .

[11]  S. Oparil,et al.  Guide to Preventive Cardiology for Women , 1999 .

[12]  J. Ensign Quality of health care: the views of homeless youth. , 2004, Health services research.

[13]  G. Tognoni,et al.  Patterns of practice for acute myocardial infarction in a population from ten countries , 1999, European Journal of Clinical Pharmacology.

[14]  Problems for clinical judgement: 4. Surviving in the report card era. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[15]  H. Krumholz,et al.  National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.

[16]  J. Avorn,et al.  Cost-Effectiveness of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Therapy in Older Patients with Myocardial Infarction , 2000, Annals of Internal Medicine.

[17]  J. Deckers,et al.  Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey. , 1999, European heart journal.

[18]  D. Illingworth,et al.  Management of hypercholesterolemia. , 2001, The Medical clinics of North America.

[19]  D. Bramlet,et al.  Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists. , 1997, The American journal of cardiology.

[20]  C. Ellenbecker,et al.  Using insurance claims data and medical record reviews to assess the quality of medical care. , 1997, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

[21]  B. McNeil,et al.  Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. , 2000, Circulation.

[22]  B. Psaty,et al.  Cost-minimization and the number needed to treat in uncomplicated hypertension. , 1998, American journal of hypertension.

[23]  T. Pearson,et al.  The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. , 1997, The American journal of cardiology.

[24]  Hudson Jw,et al.  Cholesterol measurement and treatment in community practices. , 1990 .

[25]  R. Stables,et al.  An audit of lipid screening and management in patients undergoing diagnostic cardiac catheterization. Brompton House Officer Audit Group. , 1996, European heart journal.

[26]  Robert H. Brook,et al.  Part 2: Measuring Quality of Care , 1996 .

[27]  T. Bowker,et al.  A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). , 1996, Heart.

[28]  J. McMurray The health economics of the treatment of hyperlipidemia and hypertension. , 1999, American journal of hypertension.

[29]  M. Armitage,et al.  Secondary prevention of coronary heart disease in primary care: a healthy heart initiative. , 1999, QJM : monthly journal of the Association of Physicians.

[30]  K. Teo,et al.  Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987-92. Relative importance of age, sex, and medical therapy. , 1994, Chest.

[31]  S. Oparil,et al.  AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology. , 1999, Journal of the American College of Cardiology.

[32]  Sidney C. Smith,et al.  Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. , 1999, The American journal of cardiology.

[33]  L Goldman,et al.  The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. , 2001, Journal of the American College of Cardiology.

[34]  S. M. Putnam,et al.  The Validity of the Medical Record , 1981, Medical care.

[35]  P Glassman,et al.  How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. , 2000, The American journal of medicine.